Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

NVAX:US

8.8300 USD 0.2600 3.03%

As of 17:20:00 ET on 03/04/2015.

Company Profile for Novavax Inc (NVAX)

Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.

Contact Information

Novavax Inc

9920 Belward Campus Drive
Rockville, MD 20850
United States
Phone: 1-240-268-2000

Key Executives for Novavax Inc (NVAX)

Stanley C ErckPresident/CEOBarclay A Phillips "Buck"Senior VP/CFO/Treasurer
Russell P Wilson "Rip"Senior VP:Business DevelopmentJohn J TrizzinoSenior VP:Commercial Operations
Timothy J HahnSenior VP:ManufacturingCynthia N Oliver "Cindy"Senior VP:Process Dev Ops
Gregory M Glenn "Greg"Senior VP:Research & DevelopmentLouis Fries III "Lou"VP/Chief Medical Officer
Jill HoytVP:HR & AdministrationD Nigel ThomasVP:Clinical Operations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil